title: Immunological Characteristics of a Patient With Belatacept-Resistant Acute Rejection After Face Transplantation.
authors.affiliation: Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.|Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Krezdorn
authors.affiliation: Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: N
authors.initials: N
authors.lastname: Murakami
authors.affiliation: Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: B
authors.initials: B
authors.lastname: Pomahac
authors.affiliation: Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. lriella@bwh.harvard.edu.
authors.forename: L V
authors.initials: LV
authors.lastname: Riella
mesh_terms: D000069594:Abatacept / Q000008:administration & dosage / Q000009:adverse effects*; D000208:Acute Disease; D004351:Drug Resistance; D054445:Facial Transplantation; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology*; D006085:Graft Survival; D006801:Humans; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D013601:T-Lymphocytes / Q000166:cytology*
chemical_list: D007166:Immunosuppressive Agents; D000069594:Abatacept
keywords: T cell biology; clinical research/practice; editorial/personal viewpoint; fusion proteins and monoclonal antibodies: belatacept; immunobiology; immunosuppressant; immunosuppression/immune modulation; immunosuppressive regimens; maintenance; rejection: acute; side effects; vascularized composite and reconstructive transplantation